A detailed history of Calamos Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 26,945 shares of NTRA stock, worth $4.36 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26,945
Previous 47,588 43.38%
Holding current value
$4.36 Million
Previous $5.15 Million 33.55%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$97.75 - $129.67 $2.02 Million - $2.68 Million
-20,643 Reduced 43.38%
26,945 $3.42 Million
Q2 2024

Jul 25, 2024

SELL
$85.28 - $112.6 $455,992 - $602,072
-5,347 Reduced 10.1%
47,588 $5.15 Million
Q1 2024

May 08, 2024

SELL
$59.21 - $92.9 $104,683 - $164,247
-1,768 Reduced 3.23%
52,935 $4.84 Million
Q4 2023

Jan 31, 2024

BUY
$37.55 - $62.64 $2.05 Million - $3.43 Million
54,703 New
54,703 $3.43 Million
Q2 2023

Jul 28, 2023

BUY
$47.08 - $55.16 $174,243 - $204,147
3,701 Added 17.2%
25,222 $1.23 Million
Q1 2023

May 03, 2023

BUY
$36.57 - $58.29 $787,022 - $1.25 Million
21,521 New
21,521 $1.19 Million
Q3 2022

Oct 24, 2022

BUY
$36.93 - $56.68 $3.44 Million - $5.27 Million
93,032 New
93,032 $4.08 Million
Q4 2021

Feb 01, 2022

SELL
$86.26 - $119.0 $3.46 Million - $4.78 Million
-40,169 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$100.17 - $126.36 $311,929 - $393,485
3,114 Added 8.4%
40,169 $4.48 Million
Q2 2021

Jul 22, 2021

BUY
$86.05 - $119.72 $1.71 Million - $2.38 Million
19,906 Added 116.08%
37,055 $4.21 Million
Q1 2021

Apr 12, 2021

SELL
$91.47 - $124.36 $2.92 Million - $3.97 Million
-31,893 Reduced 65.03%
17,149 $1.74 Million
Q4 2020

Jan 27, 2021

BUY
$66.66 - $111.74 $535,546 - $897,719
8,034 Added 19.59%
49,042 $4.88 Million
Q3 2020

Oct 26, 2020

BUY
$45.89 - $72.67 $815,235 - $1.29 Million
17,765 Added 76.43%
41,008 $2.96 Million
Q2 2020

Jul 27, 2020

BUY
$26.36 - $49.86 $612,685 - $1.16 Million
23,243 New
23,243 $1.16 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.